Shaheen Islam
Pulmonary Disease · Augusta, GANPI 1497727739
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (47.4%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Cook Incorporated at 32.8% of the total. Reporting peaked in 2022 at $7,039 and has fallen 60.7% since, to $2,764 in 2025. Among pulmonary disease clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 88 payments — averaging $254.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cook Incorporated$7K
- Pinnacle Biologics, Inc$7K
- Intuitive Surgical$2K
- Body Vision Medical Inc.$2K
- Medical Device Business Services, Inc.$1K
- Pulmonx Corporation$943
- plus $3K from 15 others
What the payments were for
- Consulting fees$8004%
- Speaking & faculty fees$8,34037%
- Travel & lodging$10,61247%
- Food & beverage$2,62212%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cook Incorporated | 2 | $7,340 |
| Pinnacle Biologics, Inc | 29 | $6,972 |
| Intuitive Surgical | 15 | $1,684 |
| Body Vision Medical Inc. | 8 | $1,586 |
| Medical Device Business Services, Inc. | 3 | $1,202 |
| Pulmonx Corporation | 5 | $943 |
| Medtronic | 6 | $772 |
| Coaptech, Inc. | 1 | $748 |
| Cook Medical LLC | 3 | $342 |
| Johnson & Johnson | 4 | $278 |
| AstraZeneca | 1 | $177 |
| Steris Corporation | 1 | $89 |
| Inari Medical, Inc. | 1 | $51 |
| Shionogi Inc | 1 | $35 |
| Actelion Pharmaceuticals US, Inc. | 1 | $30 |
| Ambu Inc. | 2 | $27 |
| Boehringer Ingelheim | 1 | $27 |
| United Therapeutics Corporation | 1 | $22 |
| Olympus America Inc. | 1 | $21 |
| Aurinia Pharma U.S., Inc. | 1 | $18 |
| Mylan Specialty L.p. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Blue Rhino$6,801
- Photofrin$6,064
- Da Vinci Surgical System$1,544
- LungVision$1,331
- MONARCH$1,202
- Pulmonx Endobronchial Valve EBV$801
- Cook Medical Needles$800
- PUMA SYSTEM$748
- ILLUMISITE$672
- Monarch Platform$148
How this compares
$22,374 in reported general payments places this provider in the 90th percentile of 365 pulmonary disease providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Augusta
- Carmel JosephAugusta$43K
- Varsha KulkarniAugusta$19K
- Scott PethkeAugusta$14K
- Lawrence McDermottSavannah$963K
- Vivek SambharaGainesville$417K
- Chad MillerAustell$382K
- Nehal BhattAthens$371K
- Maria MascoloRincon$358K
- Colin SwensonAtlanta$255K
- David MillerDecatur$206K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.